Amgen Inc.

AMGN · NasdaqGS

Price$0.00+0.00 (+0.00%)

Price History

Volume & Moving Averages

Price50D200D

Analyst Price Target

$0.00▼ 0.0% below current price

Range: $0.00 – $0.00 · 0 analysts

Based on Wall Street analyst estimates — not a Stockinder prediction.

About the company

Jarvis is thinking

Key Metrics

Report card

Open as standalone page ↗

Jarvis is thinking

Recent Notable Coverage

Jarvis is thinking

Report Card

Growth

Health

Risk

Value

Quality

Ownership

Insider and institutional holdings, from Yahoo Finance — for Indian companies this roughly tracks promoter (insiders) and combined FII/DII (institutions) stakes, though not split out the same way a shareholding-pattern filing would.

Insiders0.2%

Institutions85.1%

Public / Other

Income Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Total money the company brought in from its core business during the period, before any costs are subtracted.	$36.75B	$33.42B	$28.19B	$26.32B	$25.98B	$25.42B	$23.36B	-$21.00M	$22.85B	$22.99B
The direct costs of producing what was sold — raw materials, manufacturing, direct labor.	$12.04B	$12.86B	$8.45B	$6.41B	$6.45B	$6.16B	$4.36B	$4.10B	$4.07B	$4.16B
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	$9.08B	$7.26B	$7.90B	$9.57B	$7.64B	$9.14B	$9.67B	$10.26B	$9.97B	$9.79B
Operating income as a percentage of revenue.	24.7%	21.7%	28.0%	36.3%	29.4%	35.9%	41.4%	-48871.4%	43.6%	42.6%
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	$7.71B	$4.09B	$6.72B	$6.55B	$5.89B	$7.26B	$7.84B	$8.39B	$1.98B	$7.72B
Net income divided by the number of shares outstanding — profit attributable to each share.	$14.33	$7.62	$12.56	$12.18	$10.34	$12.40	$12.96	$12.00	$2.00	$10.00
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$14.23	$7.56	$12.49	$12.11	$10.28	$12.31	$12.88	$12.00	$2.00	$10.00

Balance Sheet

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$9.13B	$11.97B	$10.94B	$7.63B	$7.99B	$6.27B	$6.04B	$6.95B	$3.80B	$3.24B
Everything the company owns that has value — cash, property, inventory, investments, and more.	$90.59B	$91.84B	$97.15B	$65.12B	$61.16B	–	$59.71B	$66.42B	$79.95B	$77.63B
All of the company's interest-bearing borrowings, short and long term combined.	$54.60B	$60.10B	$64.61B	$38.95B	$33.31B	$32.99B	$29.90B	$33.93B	$35.34B	$34.60B
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$8.66B	$5.88B	$6.23B	$3.66B	$6.70B	–	$9.67B	$12.50B	$25.24B	$29.88B

Cash Flow Statement

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	$9.96B	$11.49B	$8.47B	$9.72B	$9.26B	$10.50B	$9.15B	$11.30B	$11.18B	$10.35B
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$1.86B	$1.10B	$1.11B	$936.00M	$880.00M	$608.00M	$618.00M	$738.00M	$664.00M	$738.00M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	$8.10B	$10.39B	$7.36B	$8.79B	$8.38B	$9.89B	$8.53B	$10.56B	$10.51B	$9.62B

	You	Peer avg
P/E	24.5	71.0
Revenue Growth	+9.5%	+3042.9%
ROE	91.5%	-61.0%

Amgen Inc.

Price History

Volume & Moving Averages

Analyst Price Target

About the company

Key Metrics

Report card

Jarvis Analysis

Recent Notable Coverage

Report Card

Ownership

Quick Actions

Reports & Coverage

Con Call Reports

Board of Directors / Annual Reports

Recent Articles

Income Statement

Balance Sheet

Cash Flow Statement

Peer Comparison